Sign In
Buy CSTL
$24.69
-0.795 (-3.12%)
At Close: Jul 24, 2026
Castle Biosciences Closes $11.7M Tranche of $20M Series F Financing
02:16pm, Monday, 27'th Jul 2015
Castle Biosciences, Inc., a provider of molecular diagnostics to improve cancer treatment decisions, today announced it has closed the first tranche of a $20 mi
